PCM
AMPE

Prelude Capital Management’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Prelude Capital Management’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-7
Closed -$2K – 2195
2020
Q3 		$2K Hold
7
– – ﹤0.01% 1697
2020
Q2 		$1K Buy
+7
New +$1.16K ﹤0.01% 1899

Other funds holding AMPE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
WIC
Willis Investment Counsel Gainesville, Georgia $2.1B AUM 24.61% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $1.1B AUM 26.6% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
WWM
Western Wealth Management Golden, Colorado $2.63B AUM 21.3% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return

Prelude Capital Management's AMPE Position: Q2 2021 in Review

Prelude Capital Management sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q2 2021, closing a stake of 99 shares — an estimated $50K sold.

Prelude Capital Management first reported a position in AMPE in Q1 2021 and held it in 1 quarter. The position peaked at $50K in Q1 2021. 128 funds tracked by Wall St. Rank hold AMPE as of Q2 2021.

  • Prelude Capital Management reported no remaining Ampio Pharmaceuticals Inc. position as of Q2 2021 after selling out during the quarter.
  • Prelude Capital Management sold 99 Ampio Pharmaceuticals Inc. shares in Q2 2021, an estimated $50K.
  • Prelude Capital Management first reported a position in Ampio Pharmaceuticals Inc. in Q1 2021 and held it in 1 quarter.
  • Prelude Capital Management's Ampio Pharmaceuticals Inc. position peaked at $50K in Q1 2021.
  • 128 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q2 2021.

Based on Prelude Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.